Looking Forward to 2022, COVID-19 Will Continue to Impact Pharma in Myriad Ways
As 2021 began, the pharmaceutical topic arguably drawing the most attention was COVID-19 and the rollout of vaccines against it. Moving into 2022, the COVID pandemic unfortunately continues to dominate headlines, as the U.S. marked 1 million new cases of COVID on Jan. 3 , a single-day record for any country. However, it’s not all bad news, as the pandemic is continuing its impact across various services.
Read the source article at Welcome